Molecular therapy oncolytics.

Peer Reviewed

Open Access

Molecular therapy oncolytics.

" ... fields of oncolytic virotherapy and T cell-based therapies, Molecular Therapy-- Oncolytics considers top-quality, cutting-edge research that employs innovative molecular and cellular approaches that target cancer cells for destruction, whether by viruses, other microorganisms, vaccination...

Full description

Saved in:
Bibliographic Details
Place / Publishing House:New York, NY : : Nature Publishing Group,, [2014]-[2023]
Cambridge : : Cell Press
Publication history:Began with: 1 article number 14004 (2014); ceased with Volume 31 (December 2023).
Language:English
Physical Description:1 online resource
Notes:Refereed/Peer-reviewed
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993575546504498
lccn 2014201829
ctrlnum (DE-599)ZDB2842549-2
(OCoLC)879171460
(CKB)2670000000556853
(CONSER)--2014201829
(EXLCZ)992670000000556853
collection bib_alma
record_format marc
spelling MOL THER ONCOLYTICS
Mol Ther Oncolytics dnlm
Mol. ther. oncolytics
Molecular therapy oncolytics
Molecular therapy oncolytics.
MTO
New York, NY : Nature Publishing Group, [2014]-[2023]
<2017?-> Cambridge : Cell Press
1 online resource
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Began with: 1 article number 14004 (2014); ceased with Volume 31 (December 2023).
Refereed/Peer-reviewed
Unrestricted online access star
Articles added as received to annual volume in progress.
" ... fields of oncolytic virotherapy and T cell-based therapies, Molecular Therapy-- Oncolytics considers top-quality, cutting-edge research that employs innovative molecular and cellular approaches that target cancer cells for destruction, whether by viruses, other microorganisms, vaccination, or by transfer of cells and/or genes."
Description based on: 1, article number 14004 (2014); title from PDF header (publisher's Web site, viewed Sept. 11, 2015).
Latest issue consulted: Volume 11 (2018) (Cell Press web site, viewed November 26, 2018).
Cancer Treatment Periodicals.
Viruses Therapeutic use Periodicals.
Cellular therapy Periodicals.
Neoplasms.
Genetic Therapy.
Molecular Biology.
Cancer Treatment. fast (OCoLC)fst00845538
Cellular therapy. fast (OCoLC)fst00850322
Viruses Therapeutic use. fast (OCoLC)fst01167787
Oncology
Periodical.
Fulltext.
Internet Resources.
Periodicals.
Periodicals. fast (OCoLC)fst01411641
2372-7705
language English
format Journal
title Molecular therapy oncolytics.
spellingShingle Molecular therapy oncolytics.
title_short MOL THER ONCOLYTICS
title_full Molecular therapy oncolytics.
title_fullStr Molecular therapy oncolytics.
title_full_unstemmed Molecular therapy oncolytics.
title_auth Molecular therapy oncolytics.
title_new Molecular therapy oncolytics.
title_sort molecular therapy oncolytics.
publisher Nature Publishing Group,
Cell Press
publishDate 2014
physical 1 online resource
dateSpan Began with: 1 article number 14004 (2014); ceased with Volume 31 (December 2023).
issn 2372-7705
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC271
callnumber-sort RC 3271 C44
genre Periodical.
Fulltext.
Internet Resources.
Periodicals.
Periodicals. fast (OCoLC)fst01411641
genre_facet Periodicals.
Periodical.
Fulltext.
Internet Resources.
illustrated Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.99406
dewey-sort 3616.99406
dewey-raw 616.99406
dewey-search 616.99406
oclc_num 879171460
status_str n
ids_txt_mv (DE-599)ZDB2842549-2
(OCoLC)879171460
(CKB)2670000000556853
(CONSER)--2014201829
(EXLCZ)992670000000556853
carrierType_str_mv cr
is_hierarchy_title Molecular therapy oncolytics.
_version_ 1805368547196534784
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nas-a2200673-i-4500</leader><controlfield tag="001">993575546504498</controlfield><controlfield tag="005">20240129213017.0</controlfield><controlfield tag="006">m-----o--d--------</controlfield><controlfield tag="007">cr-|||||||||||</controlfield><controlfield tag="008">140505d20142023mau-x-p-o-----0---a0eng--</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 2014201829</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">101666776</subfield><subfield code="2">DNLM</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)ZDB2842549-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)879171460</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)2670000000556853</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CONSER)--2014201829</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)992670000000556853</subfield></datafield><datafield tag="037" ind1=" " ind2=" "><subfield code="b">Nature Publishing Group, 75 Varick Street, 9th Floor, New York, NY 10013</subfield></datafield><datafield tag="042" ind1=" " ind2=" "><subfield code="a">pcc</subfield><subfield code="a">nsdp</subfield></datafield><datafield tag="050" ind1="0" ind2="0"><subfield code="a">RC271.C44</subfield></datafield><datafield tag="060" ind1="0" ind2="0"><subfield code="a">W1</subfield></datafield><datafield tag="082" ind1="0" ind2="0"><subfield code="a">616.99406</subfield><subfield code="2">23</subfield></datafield><datafield tag="210" ind1=" " ind2=" "><subfield code="a">MOL THER ONCOLYTICS</subfield></datafield><datafield tag="210" ind1="1" ind2="0"><subfield code="a">Mol Ther Oncolytics</subfield><subfield code="2">dnlm</subfield></datafield><datafield tag="210" ind1="0" ind2=" "><subfield code="a">Mol. ther. oncolytics</subfield></datafield><datafield tag="222" ind1=" " ind2="0"><subfield code="a">Molecular therapy oncolytics</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Molecular therapy oncolytics.</subfield></datafield><datafield tag="246" ind1="1" ind2=" "><subfield code="a">MTO</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY :</subfield><subfield code="b">Nature Publishing Group,</subfield><subfield code="c">[2014]-[2023]</subfield></datafield><datafield tag="264" ind1="3" ind2="1"><subfield code="3">&lt;2017?-&gt;</subfield><subfield code="a">Cambridge :</subfield><subfield code="b">Cell Press</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="362" ind1="1" ind2=" "><subfield code="a">Began with: 1 article number 14004 (2014); ceased with Volume 31 (December 2023).</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Refereed/Peer-reviewed</subfield></datafield><datafield tag="506" ind1="0" ind2=" "><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="515" ind1=" " ind2=" "><subfield code="a">Articles added as received to annual volume in progress.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">" ... fields of oncolytic virotherapy and T cell-based therapies, Molecular Therapy-- Oncolytics considers top-quality, cutting-edge research that employs innovative molecular and cellular approaches that target cancer cells for destruction, whether by viruses, other microorganisms, vaccination, or by transfer of cells and/or genes."</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: 1, article number 14004 (2014); title from PDF header (publisher's Web site, viewed Sept. 11, 2015).</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Latest issue consulted: Volume 11 (2018) (Cell Press web site, viewed November 26, 2018).</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="v">Periodicals.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Viruses</subfield><subfield code="x">Therapeutic use</subfield><subfield code="v">Periodicals.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cellular therapy</subfield><subfield code="v">Periodicals.</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Neoplasms.</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Genetic Therapy.</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Molecular Biology.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer</subfield><subfield code="x">Treatment.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst00845538</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cellular therapy.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst00850322</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Viruses</subfield><subfield code="x">Therapeutic use.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst01167787</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Oncology</subfield></datafield><datafield tag="655" ind1=" " ind2="2"><subfield code="a">Periodical.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Fulltext.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Internet Resources.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Periodicals.</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Periodicals.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst01411641</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="x">2372-7705</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">JOURNAL</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-07-23 11:22:24 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2014-05-03 20:46:25 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAJ Directory of Open Access Journals</subfield><subfield code="P">DOAJ Directory of Open Access Journals</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5342233910004498&amp;Force_direct=true</subfield><subfield code="Z">5342233910004498</subfield><subfield code="m"> Available from 2014 until 2023.</subfield><subfield code="b">Available</subfield><subfield code="8">5342233910004498</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="Z">5342233910004498</subfield><subfield code="A">2014</subfield><subfield code="B">2023</subfield></datafield></record></collection>

Similar Items